je.st
news
Tag: study
GMO battles over 'settled' science spur new study of crops
2014-11-12 00:32:47| Chemicals - Topix.net
Monsanto Co., the world's largest seed company, and its brethren of global biotech crop developers are spreading the word that as far as the safety of their genetically modified grain goes, the science is solidly on their side. The message of "settled" science has become the rallying cry for defenders of the crops and food commonly referred to as GMOs as they push back against consumers, environmentalists, lawmakers and others who want the crops labeled, restricted or banned.
Tags: science
study
settled
crops
Global demand for protective packaging on rise: study
2014-11-11 19:08:00| Canadian Plastics Headlines
World demand for protective packaging is projected to increase 6.1 per cent annually to nearly $27 billion in 2018, according to a new study by market research firm the Freedonia Group.
Tags: study
global
rise
demand
Merck Announces Results from Phase 2 Study of Investigational Chronic Hepatitis C Treatment Grazoprevir/Elbasvir in Genotype 1 Infected Treatment-Nave and Difficult-to-Cure Patients
2014-11-11 14:00:00| Merck.com - Research & Development News
Dateline City: BOSTON Final Results from the C-WORTHy Study (Parts A and B) Presented at The Liver Meeting and Published in The Lancet First Wave of Phase 3 Development Program for Grazoprevir/Elbasvir is Fully Enrolled; Merck Plans to Submit New Drug Application in 2015 BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from a multi-arm Phase 2 clinical trial evaluating grazoprevir/elbasvir (MK-5172/MK-8742, the companys investigational NS3/4A protease inhibitor and NS5A inhibitor, respectively) with or without ribavirin (RBV) in treatment-nave and previously-treated (with peg-interferon/ribavirin [PR]) patients with chronic hepatitis C virus (HCV) genotype 1 (GT1) infection -- the C-WORTHy study (Parts A and B). Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
study
treatment
phase
Public Views of Climate Science Hinge on Solutions, Study Finds
2014-11-10 18:02:00| Climate Ark Climate Change & Global Warming Newsfeed
Yale Environment 360: People often evaluate scientific evidence not on the basis of its perceived merits, but on whether they agree with the policy implications of the research, according to a study published in the Journal of Personality and Social Psychology. Using issues like climate change and air pollution as test cases, Duke University researchers sought to determine if what they call a "solution aversion" bias could be detected among self-identified Republican or Democratic survey participants. In one example,...
Tags: public
science
study
views
Study: Global warming worsening watery dead zones
2014-11-10 17:59:00| Climate Ark Climate Change & Global Warming Newsfeed
Associated Press: Global warming is likely playing a bigger role than previously thought in dead zones in oceans, lakes and rivers around the world and it's only going to get worse, according to a new study. Dead zones occur when fertilizer runoff clogs waterways with nutrients, such as nitrogen and phosphorous. That leads to an explosion of microbes that consumes oxygen and leaves the water depleted of oxygen, harming marine life. Scientists have long known that warmer water increases this problem, but a new...
Tags: study
global
dead
warming
Sites : [581] [582] [583] [584] [585] [586] [587] [588] [589] [590] [591] [592] [593] [594] [595] [596] [597] [598] [599] [600] next »